Locations
Cambridge, MA, USA · Woburn, MA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2015
Zumutor Biologics is a pioneering Immuno-Oncology company focused on targeted NK cell therapeutics. Utilizing their proprietary Human Antibody platform INABLR™, they develop first-in-class therapeutic antibodies that enhance innate immunity and modulate the tumor microenvironment. Founded in 2013 and headquartered in Cambridge, MA, with a laboratory in Bangalore, India, Zumutor has successfully raised $26 million in capital and achieved significant milestones, including global licensing of a biologic product for breast cancer treatment. Their innovative approach and experienced team position them strongly in the competitive landscape of immunotherapy.
Something looks off?